首页> 美国卫生研究院文献>Cancer Science >The Sprouty/Spred family as tumor suppressors: Coming of age
【2h】

The Sprouty/Spred family as tumor suppressors: Coming of age

机译:Sprouty / Spred家族作为抑癌药:即将成熟

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The Ras/Raf/ERK pathway is one of the most frequently dysregulated signaling pathways in various cancers. In some such cancers, Ras and Raf are hotspots for mutations, which cause continuous activation of this pathway. However, in some other cancers, it is known that negative regulators of the Ras/Raf/ERK pathway are responsible for uncontrolled activation. The Sprouty/Spred family is broadly recognized as important negative regulators of the Ras/Raf/ERK pathway, and its expression is downregulated in many malignancies, leading to hyperactivation of the Ras/Raf/ERK pathway. After the discovery of this family, intensive research investigated the mechanism by which it suppresses the Ras/Raf/ERK pathway and its roles in developmental and pathophysiological processes. In this review, we discuss the complicated roles of the Sprouty/Spred family in tumor initiation, promotion, and progression and its future therapeutic potential.
机译:Ras / Raf / ERK途径是各种癌症中最常失调的信号传导途径之一。在某些此类癌症中,Ras和Raf是突变的热点,突变会导致该途径的持续激活。但是,在其他一些癌症中,已知Ras / Raf / ERK通路的负调控因子是导致不受控制的激活的原因。 Sprouty / Spred家族被广泛认为是Ras / Raf / ERK途径的重要负调控因子,其表达在许多恶性肿瘤中均被下调,导致Ras / Raf / ERK途径的过度激活。在发现该家族后,深入的研究调查了其抑制Ras / Raf / ERK途径的机制及其在发育和病理生理过程中的作用。在这篇综述中,我们讨论了Sprouty / Spred家族在肿瘤起始,促进和发展中的复杂作用及其未来的治疗潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号